CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis. [Phase 3]
Summary
Phase 3 trial of CellCept (mycophenolate mofetil) for lupus nephritis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Lupus Nephritis | Phase 3 | Status: TERMINATED | Results posted: 2014-09-25